Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.

Source:http://linkedlifedata.com/resource/pubmed/id/21105682

J. Nat. Prod. 2011 Jan 28 74 1 106-8

Download in:

View as

General Info

PMID
21105682